Ubs Group Ag Atri Cure, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Atri Cure, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 144,180 shares of ATRC stock, worth $4.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144,180
Previous 44,545
223.67%
Holding current value
$4.89 Million
Previous $1.25 Million
252.76%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding ATRC
# of Institutions
229Shares Held
47.1MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.65MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$157 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$130 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$99.2 Million1.54% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$85.8 Million0.51% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.58B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...